Drug-Resistant Genotypes and Multi-Clonality in Plasmodium falciparum Analysed by Direct Genome Sequencing from Peripheral Blood of Malaria Patients

Naturally acquired blood-stage infections of the malaria parasite Plasmodium falciparum typically harbour multiple haploid clones. The apparent number of clones observed in any single infection depends on the diversity of the polymorphic markers used for the analysis, and the relative abundance of rare clones, which frequently fail to be detected among PCR products derived from numerically dominant clones. However, minority clones are of clinical interest as they may harbour genes conferring drug resistance, leading to enhanced survival after treatment and the possibility of subsequent therapeutic failure. We deployed new generation sequencing to derive genome data for five non-propagated parasite isolates taken directly from 4 different patients treated for clinical malaria in a UK hospital. Analysis of depth of coverage and length of sequence intervals between paired reads identified both previously described and novel gene deletions and amplifications. Full-length sequence data was extracted for 6 loci considered to be under selection by antimalarial drugs, and both known and previously unknown amino acid substitutions were identified. Full mitochondrial genomes were extracted from the sequencing data for each isolate, and these are compared against a panel of polymorphic sites derived from published or unpublished but publicly available data. Finally, genome-wide analysis of clone multiplicity was performed, and the number of infecting parasite clones estimated for each isolate. Each patient harboured at least 3 clones of P. falciparum by this analysis, consistent with results obtained with conventional PCR analysis of polymorphic merozoite antigen loci. We conclude that genome sequencing of peripheral blood P. falciparum taken directly from malaria patients provides high quality data useful for drug resistance studies, genomic structural analyses and population genetics, and also robustly represents clonal multiplicity.

[1]  S. Ralph,et al.  Interaction of apicoplast-encoded elongation factor (EF) EF-Tu with nuclear-encoded EF-Ts mediates translation in the Plasmodiumfalciparum plastid. , 2011, International journal for parasitology.

[2]  R. Hallett,et al.  Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance , 2010, Malaria Journal.

[3]  Andrew Read,et al.  Exposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencing , 2010, Proceedings of the National Academy of Sciences.

[4]  J. Ouédraogo,et al.  Genetic variation in human HBB is associated with Plasmodium falciparum transmission , 2010, Nature Genetics.

[5]  S. Meshnick,et al.  The perils of PCR: can we accurately 'correct' antimalarial trials? , 2010, Trends in parasitology.

[6]  Z. Premji,et al.  Population genetic analysis of large sequence polymorphisms in Plasmodium falciparum blood-stage antigens. , 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[7]  Badria B. El-Sayed,et al.  Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum , 2010, Malaria Journal.

[8]  Heinrich Magnus Manske,et al.  LookSeq: a browser-based viewer for deep sequencing data. , 2009, Genome research.

[9]  W. Kilama,et al.  Malaria: a research agenda for the eradication era , 2009, The Lancet.

[10]  A. Mårtensson,et al.  Plasmodium falciparum multidrug resistance protein 1 and artemisinin-based combination therapy in Africa. , 2009, The Journal of infectious diseases.

[11]  C. Plowe,et al.  Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming ‘vaccine resistant malaria’ , 2009, Parasite immunology.

[12]  Kenny Q. Ye,et al.  Sensitive and accurate detection of copy number variants using read depth of coverage. , 2009, Genome research.

[13]  P. Chiodini,et al.  Novel pfdhps Haplotypes among Imported Cases of Plasmodium falciparum Malaria in the United Kingdom , 2009, Antimicrobial Agents and Chemotherapy.

[14]  A. Mårtensson,et al.  Polymorphism in PfMRP1 (Plasmodium falciparum Multidrug Resistance Protein 1) Amino Acid 1466 Associated with Resistance to Sulfadoxine-Pyrimethamine Treatment , 2009, Antimicrobial Agents and Chemotherapy.

[15]  G. Kiwanuka,et al.  Genetic diversity in Plasmodium falciparum merozoite surface protein 1 and 2 coding genes and its implications in malaria epidemiology: a review of published studies from 1997-2007. , 2009, Journal of vector borne diseases.

[16]  Z. Ning,et al.  Amplification-free Illumina sequencing-library preparation facilitates improved mapping and assembly of GC-biased genomes , 2009, Nature Methods.

[17]  P. Rosenthal,et al.  Complexity of Plasmodium falciparum clinical samples from Uganda during short-term culture. , 2008, The Journal of infectious diseases.

[18]  C. Sutherland Comparing Highly Efficacious Antimalarial Drugs , 2008, PLoS medicine.

[19]  P. Newton,et al.  Adaptive Copy Number Evolution in Malaria Parasites , 2008, PLoS genetics.

[20]  P. Narciso,et al.  Plasmodium falciparum multiple infections, disease severity and host characteristics in malaria affected travellers returning from Africa. , 2008, Travel medicine and infectious disease.

[21]  E. Birney,et al.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs. , 2008, Genome research.

[22]  Philip M. Kim,et al.  Paired-End Mapping Reveals Extensive Structural Variation in the Human Genome , 2007, Science.

[23]  R. Tahar,et al.  Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children. , 2007, Acta tropica.

[24]  A. Ivens,et al.  Epigenetic Silencing of Plasmodium falciparum Genes Linked to Erythrocyte Invasion , 2007, PLoS pathogens.

[25]  M. Alpers,et al.  Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity. , 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[26]  S. Meshnick,et al.  Minority-variant pfcrt K76T mutations and chloroquine resistance, Malawi. , 2007, Emerging infectious diseases.

[27]  O. Branch,et al.  Genetic diversity in the Block 2 region of the merozoite surface protein 1 (MSP-1) of Plasmodium falciparum: additional complexity and selection and convergence in fragment size polymorphism. , 2006, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[28]  R. Hallett,et al.  Chloroquine/Sulphadoxine-Pyrimethamine for Gambian Children with Malaria: Transmission to Mosquitoes of Multidrug-Resistant Plasmodium falciparum , 2006, PLoS clinical trials.

[29]  E. Eichler,et al.  Fine-scale structural variation of the human genome , 2005, Nature Genetics.

[30]  M. Ranjit,et al.  The PfCRT (K76T) point mutation favours clone multiplicity and disease severity in Plasmodium falciparum infection , 2004, Tropical medicine & international health : TM & IH.

[31]  A. Escalante,et al.  Molecular epidemiology of malaria in Cameroon. XVIII. Polymorphisms of the Plasmodium falciparum merozoite surface antigen-2 gene in isolates from symptomatic patients. , 2004, The American journal of tropical medicine and hygiene.

[32]  Peter Beerli,et al.  Early Origin and Recent Expansion of Plasmodium falciparum , 2003, Science.

[33]  N. Mühlberger,et al.  Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe , 2002, Malaria Journal.

[34]  B. Lell,et al.  New emerging Plasmodium falciparum genotypes in children during the transition phase from asymptomatic parasitemia to malaria. , 2002, The American journal of tropical medicine and hygiene.

[35]  L. McRobert,et al.  Genetic complexity of Plasmodium falciparum gametocytes isolated from the peripheral blood of treated Gambian children. , 2002, The American journal of tropical medicine and hygiene.

[36]  V. do Rosário,et al.  Review: Genetic diversity of Plasmodium falciparum: asexual stages , 2002 .

[37]  M. Lebbad,et al.  Polyclonal Plasmodium falciparum malaria in travelers and selection of antifolate mutations after proguanil prophylaxis. , 2002, The American journal of tropical medicine and hygiene.

[38]  G. Snounou Genotyping of Plasmodium spp. , 2002 .

[39]  V. do Rosário,et al.  Genetic diversity of Plasmodium falciparum: asexual stages. , 2002, Tropical medicine & international health.

[40]  M. D. Wilson,et al.  Novel Plasmodium falciparum clones and rising clone multiplicities are associated with the increase in malaria morbidity in Ghanaian children during the transition into the high transmission season , 2001, Parasitology.

[41]  J. Duchemin,et al.  Association of severe malaria with a specific Plasmodium falciparum genotype in French Guiana. , 2001, The Journal of infectious diseases.

[42]  R. Carter,et al.  Detection of low level Plasmodium falciparum gametocytes using reverse transcriptase polymerase chain reaction. , 1999, Molecular and biochemical parasitology.

[43]  G. Langsley,et al.  A primary malarial infection is composed of a very wide range of genetically diverse but related parasites. , 1998, The Journal of clinical investigation.

[44]  B. Lell,et al.  Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambaréné, Gabon. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[45]  G. Snounou,et al.  Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area. , 1997, The American journal of tropical medicine and hygiene.

[46]  D. Bradley,et al.  The risk of malaria in travellers to Thailand. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[47]  A. Scherf,et al.  Multiple infections and unusual distribution of block 2 of the MSA1 gene of Plasmodium falciparum detected in west African clinical isolates by polymerase chain reaction analysis. , 1991, Molecular and biochemical parasitology.

[48]  E. Kimura,et al.  Genetic diversity in the major merozoite surface antigen of Plasmodium falciparum: high prevalence of a third polymorphic form detected in strains derived from malaria patients. , 1990, Gene.

[49]  L. Corcoran,et al.  Molecular karyotype of Plasmodium falciparum: conserved linkage groups and expendable histidine-rich protein genes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.